<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TPP</journal-id>
<journal-id journal-id-type="hwp">sptpp</journal-id>
<journal-title>Therapeutic Advances in Psychopharmacology</journal-title>
<issn pub-type="ppub">2045-1253</issn>
<issn pub-type="epub">2045-1261</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/2045125312467346</article-id>
<article-id pub-id-type="publisher-id">10.1177_2045125312467346</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The emergence of obsessive compulsive and compulsive buying symptomatology after acute stress and short-term use of ribavirin: case reports</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Karakaş Uğurlu</surname><given-names>Görkem</given-names></name>
<aff id="aff1-2045125312467346">Ministry of Health Ankara Atatürk Training and Research Hospital, Bilkent road, Number: 3 Bilkent / Ankara 06800, Turkey</aff>
</contrib>
<contrib contrib-type="author">
<name><surname>Uğurlu</surname><given-names>Mustafa</given-names></name>
<aff id="aff2-2045125312467346">Department of Psychiatry, Ministry of Health Ankara Atatürk Training and Research Hospital, Republic of Turkey</aff>
</contrib>
<contrib contrib-type="author">
<name><surname>Çayköylü</surname><given-names>Ali</given-names></name>
<aff id="aff3-2045125312467346">Department of Psychiatry, Yıldırım Beyazıt University Ankara Atatürk Training and Research Hospital, Republic of Turkey</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="corresp1-2045125312467346"><email>dr_gorkem@yahoo.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>3</volume>
<issue>4</issue>
<fpage>246</fpage>
<lpage>250</lpage>
<permissions>
<copyright-statement>© The Author(s), 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<sec id="section1-2045125312467346" sec-type="intro">
<title>Introduction</title>
<p>Neuropsychiatric side-effects have been reported in up to 60% of patients undergoing treatment with antiviral agents [<xref ref-type="bibr" rid="bibr10-2045125312467346">Evon <italic>et al</italic>. 2009</xref>]. Most of them (48%) were depressive disorders. More rarely, signs and symptoms associated with anxiety, sleep, memory and attention disorders were observed [<xref ref-type="bibr" rid="bibr23-2045125312467346">Lochet <italic>et al</italic>. 2003</xref>; <xref ref-type="bibr" rid="bibr46-2045125312467346">Ward and Curtin, 2006</xref>]. Ribavirin, an antiviral agent, has also been reported to cause some psychiatric syndromes, however it is stressed that these effects are often enhanced by the psychiatric side-effects of the other antiviral agents (such as interferon alpha) which are often used together [<xref ref-type="bibr" rid="bibr36-2045125312467346">Reichard <italic>et al</italic>. 1997</xref>; <xref ref-type="bibr" rid="bibr27-2045125312467346">Martin-Santos <italic>et al</italic>. 2008</xref>]. We would like to report a case of single-agent ribavirin-induced compulsive buying.</p>
<p>The purpose of this case report is to draw attention to obsessive compulsive spectrum disorders (OCSDs) such as compulsive buying, which, although not defined as a disorder by the DSM and ICD, may cause clinically significant disability, and also to its etiology of biological and psychological explanations.</p>
<p>A 34-year-old woman presented to our clinic with obsessive fears of becoming contaminated by microbes whenever she touches any item, continuous thoughts of having forgotten to turn the lights off and close windows and doors, uncontrolled repetitive behaviors in the form of a compulsive need to constantly check the doors or lights or continuously wash her hands. She also had sudden and intense desires to shop and purchase things needlessly. When she postponed the desire to shop, she experienced severe discomfort and restlessness. She gained relief by buying unnecessary things, hence she faced economical problems due to excessive expenditure, resulting in regret and anxiety feelings.</p>
<p>Three weeks prior to her application, she received a prophylaxis treatment consisting of 1000 mg/day oral ribavirin applied for 7 days since she had pricked her finger with a syringe that had been used on a patient with Crimean-Congo hemorrhagic fever disease. During the medication usage she had no complaint other than a feeling of dizziness and lack of concentration. The prophylaxis treatment for Crimean-Congo hemorrhagic fever disease was completed and the disease did not appear. The aforementioned psychiatric symptoms and complaints started a week after the completion of this treatment with ribavirin.</p>
<p>It was determined via psychiatric examination that she was in an anxious–angry mood, her thoughts included suspicion and contamination obsessions, control and washing compulsions, and intense desire to go shopping; her behavior of purchasing unnecessary things was noted and, after purchasing, she experienced thoughts of guilt. Routine hematological and biochemical parameters were normal. Tests also revealed a Beck Depression Inventory score of 6, Beck Anxiety Inventory score of 7, Yale–Brown Obsessive Compulsive Scale score of 15, Brief Symptom Inventory overall average symptom score of 0.51, obsessive–compulsive symptoms subscale score of 1.3, and interpersonal sensitivity subscale score of 0.66.</p>
<p>The patient had received 6 months’ treatment with paroxetine 20 mg/day for the diagnosis of depressive disorder after her father’s death in 2004. She recovered after this treatment and had not had any psychiatric complaints since then. She had no other medical disease. Her aunt was receiving treatment for a diagnosis of obsessive–compulsive disorder (OCD).</p>
<p>As a result of these signs and symptoms, cognitive–behavioral treatment was planned with this patient, diagnosed with ribavirin-induced subthreshold OCD and compulsive buying (an impulse control disorder not otherwise specified [ICD-10 F63.9]).</p>
<p>A decrease in obsessive–compulsive complaints was seen in the second week. Behavioral recommendations were given for compulsive buying (make a list before shopping, take only enough cash for the items on the list, do not use a credit card, do not go shopping alone). After 1 month of treatment the obsessive–compulsive symptoms disappeared completely but, although at a decreased level, the patient’s complaints of compulsive buying still continued.</p>
</sec>
<sec id="section2-2045125312467346" sec-type="discussion">
<title>Discussion</title>
<p>With this case, besides discussing the position of compulsive buying in psychiatry practice and its relationship with OCDs, the possibility of immunological and psychological mechanisms in its etiology is also discussed.</p>
<p>Compulsive buying can be evaluated as a separate clinical entity or may take place in the category of impulse control disorders [<xref ref-type="bibr" rid="bibr39-2045125312467346">Schlosser <italic>et al</italic>. 1994</xref>; <xref ref-type="bibr" rid="bibr28-2045125312467346">McElroy <italic>et al</italic>. 1995</xref>]. Also, in this case, the symptoms of compulsive buying were intertwined with subclinical OCD. Besides this association (comorbidity), these similarities, which are held responsible for the etiology in the properties of neurotransmitter dysregulation, demographic, clinical and treatment response, cause these clinical entities to be considered in the same spectrum [<xref ref-type="bibr" rid="bibr35-2045125312467346">Ravindran <italic>et al</italic>. 2009</xref>].</p>
<p>As with the other OCSDs, together with theetiology of compulsive buying not being clear, developmental, neurobiological, cultural andpsychological factors are thought to be effective [<xref ref-type="bibr" rid="bibr2-2045125312467346">Aboujaoude and Koran, 2010</xref>]. There are studies in OCSD that demonstrate disruptions in the corticostriatal system and also there are similarities in the hypotheses related to the etiology of OCD [<xref ref-type="bibr" rid="bibr18-2045125312467346">Hounie <italic>et al</italic>. 2007</xref>; <xref ref-type="bibr" rid="bibr13-2045125312467346">Fontenelle <italic>et al</italic>. 2011</xref>]. The effect of the immune system in the etiology of OCD and therefore OCSD has been observed [<xref ref-type="bibr" rid="bibr43-2045125312467346">Swedo <italic>et al</italic>. 1989</xref>; <xref ref-type="bibr" rid="bibr31-2045125312467346">Montgomery, 1994</xref>; <xref ref-type="bibr" rid="bibr38-2045125312467346">Sasson and Zohar, 1996</xref>]. It is thought that the natural immune response and immune cytokines affect the monoamine system in general, having a particular influence on the serotoninergic and dopaminergic systems, and therefore can cause affective, cognitive and behavioral changes [<xref ref-type="bibr" rid="bibr21-2045125312467346">Kronfol and Remick, 2000</xref>; <xref ref-type="bibr" rid="bibr7-2045125312467346">Dantzer <italic>et al</italic>. 2008</xref>; <xref ref-type="bibr" rid="bibr29-2045125312467346">Miller, 2009</xref>].</p>
<p>There are reports related to some drugs that also include antiviral agents that caused OCD and OCSD [<xref ref-type="bibr" rid="bibr20-2045125312467346">Jonkers and De Haan, 2002</xref>; <xref ref-type="bibr" rid="bibr45-2045125312467346">Voon <italic>et al</italic>. 2007</xref>; <xref ref-type="bibr" rid="bibr3-2045125312467346">Alexander, 2009</xref>; <xref ref-type="bibr" rid="bibr8-2045125312467346">Di Nicola <italic>et al</italic>. 2010</xref>]. Ribavirin is a broad-spectrum antiviral drug that is not widely used and therefore its psychiatric side effects are not known [<xref ref-type="bibr" rid="bibr42-2045125312467346">Sidwell <italic>et al</italic>. 1972</xref>]. In some case reports, where ribavirin was used in conjunction with other agents such as interferon-alpha, it has been reported that psychiatric side effects occurred, including depression, fatigue, anxiety symptoms, cognitive impairment and a decrease in quality of life [<xref ref-type="bibr" rid="bibr24-2045125312467346">Maddock <italic>et al</italic>. 2005</xref>; <xref ref-type="bibr" rid="bibr1-2045125312467346">Abdel-Salam, 2006</xref>]. The mechanism behind the neuropsychiatric side-effects occurring due to ribavirin is not understood. It is thought that many drugs induce the production of antidrug antibodies at a finite rate. Although these antibodies do not usually cause clinical symptoms, they can rarely cause severe degrees of clinical cases [<xref ref-type="bibr" rid="bibr41-2045125312467346">Shankar <italic>et al</italic>. 2008</xref>]. As far as we know, there is no data about the formation of antibodies related to the usage of ribavirin.</p>
<p>Independent of its antiviral effect, ribavirin is an agent that reduces the necro-inflammatory response and synthesis of proinflammatory cytokines [<xref ref-type="bibr" rid="bibr17-2045125312467346">Hoofnagle <italic>et al</italic>. 2003</xref>; <xref ref-type="bibr" rid="bibr4-2045125312467346">Barnes <italic>et al</italic>. 2004</xref>]. It also has immunomodulatory and reinforcing effects on T helper 1 (Th1) cells, and it causes modulation or immunosuppression in cytokine profiles and lymphocyte differentiation patterns [<xref ref-type="bibr" rid="bibr19-2045125312467346">Hultgren <italic>et al</italic>. 1998</xref>; <xref ref-type="bibr" rid="bibr44-2045125312467346">Tam <italic>et al</italic>. 1999</xref>; <xref ref-type="bibr" rid="bibr12-2045125312467346">Fang <italic>et al</italic>. 2000</xref>; <xref ref-type="bibr" rid="bibr22-2045125312467346">Lavrnja <italic>et al</italic>. 2008</xref>]. It can be speculated that the effects of ribavirin on the immune system, as argued in previous studies of OCD immune theory, may cause a delay in corticostriatal activity.</p>
<p>A large number of neurobiological and psychological studies have been conducted on the psychopathological consequences of acute stress. The relationship between stress and post-traumatic stress disorder is particularly well known and, as in OCD, there are common features, such as repetitive intrusive cognition [<xref ref-type="bibr" rid="bibr34-2045125312467346">Rachman and Hodgson, 1980</xref>; <xref ref-type="bibr" rid="bibr25-2045125312467346">Marks, 2001</xref>].</p>
<p>Acute stress can cause quantitative and functional changes in the cortisol, involving dihydroepiandrosterone, corticotropin-releasing hormone (CRH), locus coeruleus and norepinephrine systems, neuropeptide Y, galanin, dopamine, serotonin, benzodiazepine, GABA, gonadal steroids, antibody production and suppressor/cytotoxic and natural killer (NK) cell populations [<xref ref-type="bibr" rid="bibr6-2045125312467346">Cohen <italic>et al</italic>. 2001</xref>; <xref ref-type="bibr" rid="bibr26-2045125312467346">Marsland <italic>et al</italic>. 2001</xref>; <xref ref-type="bibr" rid="bibr5-2045125312467346">Charney, 2004</xref>; <xref ref-type="bibr" rid="bibr15-2045125312467346">Hasler <italic>et al</italic>. 2010</xref>].</p>
<p>In compulsive situations, people respond with a variety of coping strategies [<xref ref-type="bibr" rid="bibr14-2045125312467346">Hareven and Adams, 1982</xref>]. Especially intense negative emotions can lead to problematic behaviors such as alcohol or psychotropic substance use and gambling, self-injurious behavior and compulsive buying [<xref ref-type="bibr" rid="bibr33-2045125312467346">O’Guinn and Faber, 1989</xref>; <xref ref-type="bibr" rid="bibr25-2045125312467346">Marks, 2001</xref>; <xref ref-type="bibr" rid="bibr30-2045125312467346">Miltenberger <italic>et al</italic>. 2003</xref>; <xref ref-type="bibr" rid="bibr32-2045125312467346">Nock and Prinstein, 2004</xref>; <xref ref-type="bibr" rid="bibr40-2045125312467346">Selby <italic>et al</italic>. 2008</xref>]. Hirschman mentioned that the stress of self-concept can result in a search for various types of symbolic self-complement [<xref ref-type="bibr" rid="bibr16-2045125312467346">Hirschman, 1992</xref>]. In this way, compulsiveconsumption temporary helps the repair of self-concept [<xref ref-type="bibr" rid="bibr37-2045125312467346">Rindfleisch <italic>et al</italic>. 1997</xref>]. At the same time, compulsive buying, with the advantage of euphoria, can be considered as a coping strategy during the depression or other negative emotions [<xref ref-type="bibr" rid="bibr11-2045125312467346">Faber and Christenson, 1996</xref>; <xref ref-type="bibr" rid="bibr9-2045125312467346">Dittmar and Drury, 2000</xref>].</p>
<p>We have contributed to the biological and psychological literature in the field of psychiatry for many years and, ultimately, this has lead us to the formation of the concept of ‘biopsychosocial’. In the etiology of psychiatric disorders, biological (in this case, the possible immunological effects of drugs), psychological (in this case, the effect of trauma on emotions, thoughts and behaviors), or biopsychosocial (in this case, the effect of possible structural or immunologic changes caused by psychological trauma on emotions, thoughts and behaviors) explanations are important in determining the correct treatment approaches.</p>
<p>Although it was a constraint that the necessary immunological research could not be made in this case, we think that the compulsive buying that occurred in this patient, who has a familial predisposition to OCD, was triggered by the usage of ribavirin or a psychological stressor. Therefore, whether the effects of ribavirin or psychological stressor on the immune system caused disruption in corticostriatal activity and/or created the ground for OCSD is worthy of controlled clinical and immunological studies.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Abdel-Salam</surname><given-names>O.</given-names></name>
</person-group> (<year>2006</year>) <article-title>Antinociceptive and behavioral effects of ribavirin in mice</article-title>. <source>Pharmacol Biochem Behav</source> <volume>83</volume>: <fpage>230</fpage>–<lpage>238</lpage>.</citation>
</ref>
<ref id="bibr2-2045125312467346">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Aboujaoude</surname><given-names>E.</given-names></name>
<name><surname>Koran</surname><given-names>L.</given-names></name>
</person-group> (<year>2010</year>) <source>Impulse control disorders</source>. <publisher-name>Cambridge University Press</publisher-name>, pp. <fpage>5</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr3-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Alexander</surname><given-names>J.</given-names></name>
</person-group> (<year>2009</year>) <article-title>De novo induction of obsessive-compulsive symptoms with quetiapine in a patient with borderline personality disorder</article-title>. <source>Aust N Z J Psychiatry</source> <volume>43</volume>: <fpage>1185</fpage>.</citation>
</ref>
<ref id="bibr4-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barnes</surname><given-names>E.</given-names></name>
<name><surname>Salio</surname><given-names>M.</given-names></name>
<name><surname>Cerundolo</surname><given-names>V.</given-names></name>
<name><surname>Medlin</surname><given-names>J.</given-names></name>
<name><surname>Murphy</surname><given-names>S.</given-names></name>
<name><surname>Dusheiko</surname><given-names>G.</given-names></name>
<etal/>
</person-group>. (<year>2004</year>) <article-title>Impact of alpha interferon and ribavirin on the function of maturing dendritic cells</article-title>. <source>Antimicrob Agents Chemother</source> <volume>48</volume>: <fpage>3382</fpage>–<lpage>3389</lpage>.</citation>
</ref>
<ref id="bibr5-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Charney</surname><given-names>D.</given-names></name>
</person-group> (<year>2004</year>) <article-title>Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress</article-title>. <source>Am J Psychiatry</source> <volume>161</volume>: <fpage>195</fpage>–<lpage>216</lpage>.</citation>
</ref>
<ref id="bibr6-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cohen</surname><given-names>S.</given-names></name>
<name><surname>Miller</surname><given-names>G.</given-names></name>
<name><surname>Rabin</surname><given-names>B.</given-names></name>
</person-group> (<year>2001</year>) <article-title>Psychological stress and antibody response to immunization: a critical review of the human literature</article-title>. <source>Psychosom Med</source> <volume>63</volume>: <fpage>7</fpage>–<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr7-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dantzer</surname><given-names>R.</given-names></name>
<name><surname>O’Connor</surname><given-names>J.</given-names></name>
<name><surname>Freund</surname><given-names>G.</given-names></name>
<name><surname>Johnson</surname><given-names>R.</given-names></name>
<name><surname>Kelley</surname><given-names>K.</given-names></name>
</person-group> (<year>2008</year>) <article-title>From inflammation to sickness and depression: when the immune system subjugates the brain</article-title>. <source>Nat Rev Neurosci</source> <volume>9</volume>: <fpage>46</fpage>–<lpage>56</lpage>.</citation>
</ref>
<ref id="bibr8-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Di Nicola</surname><given-names>M.</given-names></name>
<name><surname>Martinotti</surname><given-names>G.</given-names></name>
<name><surname>Mazza</surname><given-names>M.</given-names></name>
<name><surname>Tedeschi</surname><given-names>D.</given-names></name>
<name><surname>Pozzi</surname><given-names>G.</given-names></name>
<name><surname>Janiri</surname><given-names>L.</given-names></name>
</person-group> (<year>2010</year>) <article-title>Quetiapine as add-on treatment for bipolar I disorder with comorbid compulsive buying and physical exercise addiction</article-title>. <source>Prog Neuropsychopharmacol Biol Psychiatry</source> <volume>34</volume>: <fpage>713</fpage>–<lpage>714</lpage>.</citation>
</ref>
<ref id="bibr9-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dittmar</surname><given-names>H.</given-names></name>
<name><surname>Drury</surname><given-names>J.</given-names></name>
</person-group> (<year>2000</year>) <article-title>Self-image-is it in the bag? A qualitative comparison between</article-title>. <source>J Econ Psychol</source> <volume>21</volume>: <fpage>109</fpage>–<lpage>142</lpage>.</citation>
</ref>
<ref id="bibr10-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Evon</surname><given-names>D.</given-names></name>
<name><surname>Ramcharran</surname><given-names>D.</given-names></name>
<name><surname>Belle</surname><given-names>S.</given-names></name>
<name><surname>Terrault</surname><given-names>N.</given-names></name>
<name><surname>Fontana</surname><given-names>R.</given-names></name>
<name><surname>Fried</surname><given-names>M.</given-names></name>
</person-group> (<year>2009</year>) <article-title>Prospective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C study</article-title>. <source>Am J Gastroenterol</source> <volume>104</volume>: <fpage>2949</fpage>–<lpage>2958</lpage>.</citation>
</ref>
<ref id="bibr11-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Faber</surname><given-names>R.</given-names></name>
<name><surname>Christenson</surname><given-names>G.</given-names></name>
</person-group> (<year>1996</year>) <article-title>In the mood to buy: differences in the mood states experienced by compulsive buyers and other consumers</article-title>. <source>Psychol Market</source> <volume>13</volume>: <fpage>803</fpage>–<lpage>819</lpage>.</citation>
</ref>
<ref id="bibr12-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fang</surname><given-names>S.</given-names></name>
<name><surname>Hwang</surname><given-names>L.</given-names></name>
<name><surname>Chen</surname><given-names>D.</given-names></name>
<name><surname>Chiang</surname><given-names>B.</given-names></name>
</person-group> (<year>2000</year>) <article-title>Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level</article-title>. <source>J Hepatol</source> <volume>33</volume>: <fpage>791</fpage>–<lpage>798</lpage>.</citation>
</ref>
<ref id="bibr13-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fontenelle</surname><given-names>L.</given-names></name>
<name><surname>Oostermeijer</surname><given-names>S.</given-names></name>
<name><surname>Harrison</surname><given-names>B.</given-names></name>
<name><surname>Pantelis</surname><given-names>C.</given-names></name>
<name><surname>Yucel</surname><given-names>M.</given-names></name>
</person-group> (<year>2011</year>) <article-title>Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments</article-title>. <source>Drugs</source> <volume>71</volume>: <fpage>827</fpage>–<lpage>840</lpage>.</citation>
</ref>
<ref id="bibr14-2045125312467346">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Hareven</surname><given-names>T.</given-names></name>
<name><surname>Adams</surname><given-names>K.</given-names></name>
</person-group> (<year>1982</year>) <source>Ageing and Life Course Transitions: An Interdisciplinary Perspective</source>. <publisher-name>Tavistock Publications</publisher-name>.</citation>
</ref>
<ref id="bibr15-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hasler</surname><given-names>G.</given-names></name>
<name><surname>Van Der Veen</surname><given-names>J.</given-names></name>
<name><surname>Grillon</surname><given-names>C.</given-names></name>
<name><surname>Drevets</surname><given-names>W.</given-names></name>
<name><surname>Shen</surname><given-names>J.</given-names></name>
</person-group> (<year>2010</year>) <article-title>Effect of acute psychological stress on prefrontal GABA concentration determined by proton magnetic resonance spectroscopy</article-title>. <source>Am J Psychiatry</source> <volume>167</volume>: <fpage>1226</fpage>–<lpage>1231</lpage>.</citation>
</ref>
<ref id="bibr16-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hirschman</surname><given-names>E.</given-names></name>
</person-group> (<year>1992</year>) <article-title>The consciousness of addiction: toward a general theory of compulsive consumption</article-title>. <source>J Consumer Res</source> <volume>19</volume>: <fpage>155</fpage>–<lpage>179</lpage>.</citation>
</ref>
<ref id="bibr17-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hoofnagle</surname><given-names>J.</given-names></name>
<name><surname>Ghany</surname><given-names>M.</given-names></name>
<name><surname>Kleiner</surname><given-names>D.</given-names></name>
<name><surname>Doo</surname><given-names>E.</given-names></name>
<name><surname>Heller</surname><given-names>T.</given-names></name>
<name><surname>Promrat</surname><given-names>K.</given-names></name>
<etal/>
</person-group>. (<year>2003</year>) <article-title>Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin</article-title>. <source>Hepatology</source> <volume>38</volume>: <fpage>66</fpage>–<lpage>74</lpage>.</citation>
</ref>
<ref id="bibr18-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hounie</surname><given-names>A.</given-names></name>
<name><surname>Pauls</surname><given-names>D.</given-names></name>
<name><surname>DoRosario-Campos</surname><given-names>M.</given-names></name>
<name><surname>Mercadante</surname><given-names>M.</given-names></name>
<name><surname>Diniz</surname><given-names>J.</given-names></name>
<name><surname>De Mathis</surname><given-names>M.</given-names></name>
<etal/>
</person-group>. (<year>2007</year>) <article-title>Obsessive-compulsive spectrum disorders and rheumatic fever: a family study</article-title>. <source>Biol Psychiatry</source> <volume>61</volume>: <fpage>266</fpage>–<lpage>272</lpage>.</citation>
</ref>
<ref id="bibr19-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hultgren</surname><given-names>C.</given-names></name>
<name><surname>Milich</surname><given-names>D.</given-names></name>
<name><surname>Weiland</surname><given-names>O.</given-names></name>
<name><surname>Sallberg</surname><given-names>M.</given-names></name>
</person-group> (<year>1998</year>) <article-title>The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses</article-title>. <source>J Gen Virol</source> <volume>79</volume>: <fpage>2381</fpage>–<lpage>2391</lpage>.</citation>
</ref>
<ref id="bibr20-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jonkers</surname><given-names>F.</given-names></name>
<name><surname>De Haan</surname><given-names>L.</given-names></name>
</person-group> (<year>2002</year>) <article-title>Olanzapine-induced obsessive-compulsive symptoms in a patient with bipolar II disorder</article-title>. <source>Psychopharmacology (Berl)</source> <volume>162</volume>: <fpage>87</fpage>–<lpage>88</lpage>.</citation>
</ref>
<ref id="bibr21-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kronfol</surname><given-names>Z.</given-names></name>
<name><surname>Remick</surname><given-names>D.</given-names></name>
</person-group> (<year>2000</year>) <article-title>Cytokines and the brain: implications for clinical psychiatry</article-title>. <source>Am J Psychiatry</source> <volume>157</volume>: <fpage>683</fpage>–<lpage>694</lpage>.</citation>
</ref>
<ref id="bibr22-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lavrnja</surname><given-names>I.</given-names></name>
<name><surname>Stojkov</surname><given-names>D.</given-names></name>
<name><surname>Bjelobaba</surname><given-names>I.</given-names></name>
<name><surname>Pekovic</surname><given-names>S.</given-names></name>
<name><surname>Dacic</surname><given-names>S.</given-names></name>
<name><surname>Nedeljkovic</surname><given-names>N.</given-names></name><etal/>
</person-group>. (<year>2008</year>) <article-title>Ribavirin ameliorates experimental autoimmune encephalomyelitis in rats and modulates cytokine production</article-title>. <source>Int Immunopharmacol</source> <volume>8</volume>: <fpage>1282</fpage>–<lpage>1290</lpage>.</citation>
</ref>
<ref id="bibr23-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lochet</surname><given-names>P.</given-names></name>
<name><surname>Peyriere</surname><given-names>H.</given-names></name>
<name><surname>Lotthe</surname><given-names>A.</given-names></name>
<name><surname>Mauboussin</surname><given-names>J.</given-names></name>
<name><surname>Delmas</surname><given-names>B.</given-names></name>
<name><surname>Reynes</surname><given-names>J.</given-names></name>
</person-group> (<year>2003</year>) <article-title>Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz</article-title>. <source>HIV Med</source> <volume>4</volume>: <fpage>62</fpage>–<lpage>66</lpage>.</citation>
</ref>
<ref id="bibr24-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Maddock</surname><given-names>C.</given-names></name>
<name><surname>Landau</surname><given-names>S.</given-names></name>
<name><surname>Barry</surname><given-names>K.</given-names></name>
<name><surname>Maulayah</surname><given-names>P.</given-names></name>
<name><surname>Hotopf</surname><given-names>M.</given-names></name>
<name><surname>Cleare</surname><given-names>A.</given-names></name><etal/>
</person-group>. (<year>2005</year>) <article-title>Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response</article-title>. <source>Mol Psychiatry</source> <volume>10</volume>: <fpage>332</fpage>–<lpage>333</lpage>.</citation>
</ref>
<ref id="bibr25-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marks</surname><given-names>P.</given-names></name>
</person-group> (<year>2001</year>) <article-title>Traumatic experiences, post-traumatic stress disorder and obsessive-compulsive disorder</article-title>. <source>Int Rev Psych</source> <volume>13</volume>: <fpage>172</fpage>–<lpage>180</lpage>.</citation>
</ref>
<ref id="bibr26-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Marsland</surname><given-names>A.</given-names></name>
<name><surname>Cohen</surname><given-names>S.</given-names></name>
<name><surname>Rabin</surname><given-names>B.</given-names></name>
<name><surname>Manuck</surname><given-names>S.</given-names></name>
</person-group> (<year>2001</year>) <article-title>Associations between stress, trait negative affect, acute immune reactivity, and antibody response to hepatitis B injection in healthy young adults</article-title>. <source>Health Psychol</source> <volume>20</volume>: <fpage>4</fpage>–<lpage>11</lpage>.</citation>
</ref>
<ref id="bibr27-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Martin-Santos</surname><given-names>R.</given-names></name>
<name><surname>Diez-Quevedo</surname><given-names>C.</given-names></name>
<name><surname>Castellvi</surname><given-names>P.</given-names></name>
<name><surname>Navines</surname><given-names>R.</given-names></name>
<name><surname>Miquel</surname><given-names>M.</given-names></name>
<name><surname>Masnou</surname><given-names>H.</given-names></name><etal/>
</person-group>. (<year>2008</year>) <article-title>De novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis C</article-title>. <source>Aliment Pharmacol Ther</source> <volume>27</volume>: <fpage>257</fpage>–<lpage>265</lpage>.</citation>
</ref>
<ref id="bibr28-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>McElroy</surname><given-names>S.</given-names></name>
<name><surname>Keck</surname><given-names>P.</given-names><suffix>Jr</suffix></name>
<name><surname>Phillips</surname><given-names>K.</given-names></name>
</person-group> (<year>1995</year>) <article-title>Kleptomania, compulsive buying, and binge-eating disorder</article-title>. <source>J Clin Psychiatry</source> <volume>56</volume>(<supplement>Suppl. 4</supplement>): <fpage>14</fpage>–<lpage>26</lpage>; discussion 27.</citation>
</ref>
<ref id="bibr29-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Miller</surname><given-names>A.</given-names></name>
</person-group> (<year>2009</year>) <article-title>Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface</article-title>. <source>Brain Behav Immun</source> <volume>23</volume>: <fpage>149</fpage>–<lpage>158</lpage>.</citation>
</ref>
<ref id="bibr30-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Miltenberger</surname><given-names>R.</given-names></name>
<name><surname>Redlin</surname><given-names>J.</given-names></name>
<name><surname>Crosby</surname><given-names>R.</given-names></name>
<name><surname>Stickney</surname><given-names>M.</given-names></name>
<name><surname>Mitchell</surname><given-names>J.</given-names></name>
<name><surname>Wonderlich</surname><given-names>S.</given-names></name><etal/>
</person-group>. (<year>2003</year>) <article-title>Direct and retrospective assessment of factors contributing to compulsive buying</article-title>. <source>J Behav Ther Exp Psychiatry</source> <volume>34</volume>: <fpage>1</fpage>–<lpage>9</lpage>.</citation>
</ref>
<ref id="bibr31-2045125312467346">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Montgomery</surname><given-names>S.</given-names></name>
</person-group> (<year>1994</year>) <article-title>Pharmacological treatment of obsessive-compulsive disorder</article-title>. <source>Current Insights in Obsessive–Compulsive Disorder</source>. <publisher-loc>Chichester</publisher-loc>: <publisher-name>John Wiley &amp; Sons</publisher-name>, pp. <fpage>123</fpage>–<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr32-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nock</surname><given-names>M.</given-names></name>
<name><surname>Prinstein</surname><given-names>M.</given-names></name>
</person-group> (<year>2004</year>) <article-title>A functional approach to the assessment of self-mutilative behavior</article-title>. <source>J Consult Clin Psychol</source> <volume>72</volume>: <fpage>885</fpage>–<lpage>890</lpage>.</citation>
</ref>
<ref id="bibr33-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>O’Guinn</surname><given-names>T.</given-names></name>
<name><surname>Faber</surname><given-names>R.</given-names></name>
</person-group> (<year>1989</year>) <article-title>Compulsive buying: a phenomenological exploration</article-title>. <source>J Consumer Res</source> <volume>16</volume>: <fpage>147</fpage>–<lpage>157</lpage>.</citation>
</ref>
<ref id="bibr34-2045125312467346">
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Rachman</surname><given-names>S.</given-names></name>
<name><surname>Hodgson</surname><given-names>R.</given-names></name>
</person-group> (<year>1980</year>) <source>Obsessions and Compulsions</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Prentice-Hall</publisher-name>.</citation>
</ref>
<ref id="bibr35-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ravindran</surname><given-names>A.</given-names></name>
<name><surname>DaSilva</surname><given-names>T.</given-names></name>
<name><surname>Ravindran</surname><given-names>L.</given-names></name>
<name><surname>Richter</surname><given-names>M.</given-names></name>
<name><surname>Rector</surname><given-names>N.</given-names></name>
</person-group> (<year>2009</year>) <article-title>Obsessive-compulsive spectrum disorders: a review of the evidence-based treatments</article-title>. <source>Can J Psychiatry</source> <volume>54</volume>: <fpage>331</fpage>–<lpage>343</lpage>.</citation>
</ref>
<ref id="bibr36-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reichard</surname><given-names>O.</given-names></name>
<name><surname>Schvarcz</surname><given-names>R.</given-names></name>
<name><surname>Weiland</surname><given-names>O.</given-names></name>
</person-group> (<year>1997</year>) <article-title>Therapy of hepatitis C: alpha interferon and ribavirin</article-title>. <source>Hepatology</source> <volume>26</volume>: <fpage>108S</fpage>-<lpage>111S</lpage>.</citation>
</ref>
<ref id="bibr37-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rindfleisch</surname><given-names>A.</given-names></name>
<name><surname>Burroughs</surname><given-names>J.</given-names></name>
<name><surname>Denton</surname><given-names>F.</given-names></name>
</person-group> (<year>1997</year>) <article-title>Family structure, materialism, and compulsive consumption</article-title>. <source>J Consumer Res</source> <volume>23</volume>: <fpage>312</fpage>–<lpage>325</lpage>.</citation>
</ref>
<ref id="bibr38-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sasson</surname><given-names>Y.</given-names></name>
<name><surname>Zohar</surname><given-names>J.</given-names></name>
</person-group> (<year>1996</year>) <article-title>New developments in obsessive-compulsive disorder research: implications for clinical management</article-title>. <source>Int Clin Psychopharmacol</source> <volume>11</volume>(<supplement>Suppl. 5</supplement>): <fpage>3</fpage>–<lpage>12</lpage>.</citation>
</ref>
<ref id="bibr39-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Schlosser</surname><given-names>S.</given-names></name>
<name><surname>Black</surname><given-names>D.</given-names></name>
<name><surname>Repertinger</surname><given-names>S.</given-names></name>
<name><surname>Freet</surname><given-names>D.</given-names></name>
</person-group>(<year>1994</year>) <article-title>Compulsive buying. demography, phenomenology, and comorbidity in 46 subjects</article-title>. <source>Gen Hosp Psychiatry</source> <volume>16</volume>: <fpage>205</fpage>–<lpage>212</lpage>.</citation>
</ref>
<ref id="bibr40-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Selby</surname><given-names>E.</given-names></name>
<name><surname>Anestis</surname><given-names>M.</given-names></name>
<name><surname>Joiner</surname><given-names>T.</given-names></name>
</person-group> (<year>2008</year>) <article-title>Understanding the relationship between emotional and behavioral dysregulation: emotional cascades</article-title>. <source>Behav Res Ther</source> <volume>46</volume>: <fpage>593</fpage>–<lpage>611</lpage>.</citation>
</ref>
<ref id="bibr41-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shankar</surname><given-names>G.</given-names></name>
<name><surname>Devanarayan</surname><given-names>V.</given-names></name>
<name><surname>Amaravadi</surname><given-names>L.</given-names></name>
<name><surname>Barrett</surname><given-names>Y.</given-names></name>
<name><surname>Bowsher</surname><given-names>R.</given-names></name>
<name><surname>Finco-Kent</surname><given-names>D.</given-names></name><etal/>
</person-group>. (<year>2008</year>) <article-title>Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products</article-title>. <source>J Pharm Biomed Anal</source> <volume>48</volume>: <fpage>1267</fpage>–<lpage>1281</lpage>.</citation>
</ref>
<ref id="bibr42-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sidwell</surname><given-names>R.</given-names></name>
<name><surname>Huffman</surname><given-names>J.</given-names></name>
<name><surname>Khare</surname><given-names>G.</given-names></name>
<name><surname>Allen</surname><given-names>L.</given-names></name>
<name><surname>Witkowski</surname><given-names>J.</given-names></name>
<name><surname>Robins</surname><given-names>R.</given-names></name>
</person-group> (<year>1972</year>) <article-title>Broad-spectrum antiviral activity of virazole: 1-beta-d-ribofuranosyl-1,2,4-triazole-3-carboxamide</article-title>. <source>Science</source> <volume>177</volume>: <fpage>705</fpage>–<lpage>706</lpage>.</citation>
</ref>
<ref id="bibr43-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Swedo</surname><given-names>S.</given-names></name>
<name><surname>Rapoport</surname><given-names>J.</given-names></name>
<name><surname>Cheslow</surname><given-names>D.</given-names></name>
<name><surname>Leonard</surname><given-names>H.</given-names></name>
<name><surname>Ayoub</surname><given-names>E.</given-names></name>
<name><surname>Hosier</surname><given-names>D.</given-names></name><etal/>
</person-group>. (<year>1989</year>) <article-title>Highprevalence of obsessive-compulsive symptoms in patients with Sydenham’s chorea</article-title>. <source>Am J Psychiatry</source> <volume>146</volume>: <fpage>246</fpage>–<lpage>249</lpage>.</citation>
</ref>
<ref id="bibr44-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tam</surname><given-names>R.</given-names></name>
<name><surname>Pai</surname><given-names>B.</given-names></name>
<name><surname>Bard</surname><given-names>J.</given-names></name>
<name><surname>Lim</surname><given-names>C.</given-names></name>
<name><surname>Averett</surname><given-names>D.</given-names></name>
<name><surname>Phan</surname><given-names>U.</given-names></name><etal/>
</person-group>. (<year>1999</year>) <article-title>Ribavirin polarizes human T cell responses towards a type 1 cytokine profile</article-title>.<source>J Hepatol</source> <volume>30</volume>: <fpage>376</fpage>–<lpage>382</lpage>.</citation>
</ref>
<ref id="bibr45-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Voon</surname><given-names>V.</given-names></name>
<name><surname>Potenza</surname><given-names>M.</given-names></name>
<name><surname>Thomsen</surname><given-names>T.</given-names></name>
</person-group> (<year>2007</year>) <article-title>Medication-related impulse control and repetitive behaviors in Parkinson’s disease</article-title>. <source>Curr Opin Neurol</source> <volume>20</volume>: <fpage>484</fpage>–<lpage>492</lpage>.</citation>
</ref>
<ref id="bibr46-2045125312467346">
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ward</surname><given-names>D.</given-names></name>
<name><surname>Curtin</surname><given-names>J.</given-names></name>
</person-group> (<year>2006</year>) <article-title>Switch from efavirenz to nevirapine associated with resolution of efavirenz-related neuropsychiatric adverse events and improvement in lipid profiles</article-title>. <source>AIDS Patient Care STDS</source> <volume>20</volume>: <fpage>542</fpage>–<lpage>548</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>